The name change means that the company, which is behind the obesity drugs Ozempic and Wegovy, will now be called Novo.
At the same time, the bull in the company's logo is being adjusted so that the animal is turned and now looks to the right.
Novo Nordisk has been under heavy pressure recently and the stock has fallen significantly compared with previous highs.
